headache. Drug-induced headache, not elsewhere classified
Conditions
Interventions
Intervention 1: Spinal anesthesia is performed in sitting position between L4 - L5 spaces with spinal needle Quinke (25 G * 90mm) 12.5 mgbupivacaine with 5 mcg sufentanil used. Intervention 2: Spinal
Treatment - Drugs
Prevention
Spinal anesthesia is performed in sitting position between L4 - L5 spaces with spinal needle Quinke (25 G * 90mm) 12.5 mgbupivacaine with 5 mcg sufentanil used.
Spinal anesthesia is performed in sitting position between L4 - L5 spaces with spinal needle Quinke (25 G * 90mm) 12.5 mg bupivacaine used.
Sponsors
Vice chancellor for reasearch ,Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: In this study, pregnant women 18 to 40 years undergoing elective cesarean section; ASA class I, II (American Society classification ofAnesthesia); BMI of 18.5 to 25 .patiants were entered to this study after giving informed consent. Patients with a history of bleeding disorder, lack of consent to perform spinal anesthesia, infection, migraine, history of seizures, severe preeclampsia, eclampsia, history of back pain and bulky mass in the CNS are excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache incidence and intencity. Timepoint: 0 to 7 days after spinal anesthesia. Method of measurement: by visual analogue scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital sign changes. Timepoint: every 2 minute until 10minute then every 5 minute. Method of measurement: by datascope monitor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mitra Yari
Kermanshah University of Medical Sciences
Outcome results
None listed